AEGiS-APPJ: Cost-Effectiveness and Cost-Benefit Approaches in Programs Designed to Prevent AIDS

Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Cost-Effectiveness and Cost-Benefit Approaches in Programs Designed to Prevent AIDS

AIDS & Public Policy Journal 3, no. 3 (1988): 19-22
Andreas Mielck

Programs designed to prevent the spread of AIDS are increasingly necessary. The number of AIDS cases reported to the Centers for Disease Control (CDC) continues to increase in all patient groups, although the rate of increase per year had declined. As of March 21, 1988, 54,233 AIDS cases had been reported in the U.S; almost 60 percent of these cases have died. These numbers provide a good estimate of the public health problem posed by AIDS. Federal health officials began active surveillance in 1983; the level of reporting was shown to exceed 95 percent in two validation studies. To evaluate the need for specific AIDS-related programs, the cost effectiveness and cost-benefit ratio of the programs must be assessed. In this paper, these two parameters are briefly described and applied to AIDS-related programs.
880915
APPJ883305

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1986, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .